Innoviva, Inc. Files 2024 Annual Report Amendment
Ticker: INVA · Form: 10-K/A · Filed: Mar 24, 2025 · CIK: 1080014
| Field | Detail |
|---|---|
| Company | Innoviva, INC. (INVA) |
| Form Type | 10-K/A |
| Filed Date | Mar 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceuticals
TL;DR
Innoviva filed its 2024 10-K amendment on March 24th. Check for updates.
AI Summary
Innoviva, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, submitted on March 24, 2025, provides updated information for the company, which is incorporated in Delaware and headquartered in Burlingame, California. Innoviva, Inc. operates in the pharmaceutical preparations sector.
Why It Matters
This amendment to the annual report provides updated financial and operational details for Innoviva, Inc. for the fiscal year 2024, which is crucial for investors and stakeholders to assess the company's performance and outlook.
Risk Assessment
Risk Level: low — This filing is an amendment to a standard annual report and does not appear to contain significant new negative information.
Key Numbers
- 2024 — Fiscal Year End (The annual report covers the period ending December 31, 2024.)
- 10-K/A — Filing Type (This is an amended annual report filing.)
Key Players & Entities
- Innoviva, Inc. (company) — Filer of the 10-K/A
- December 31, 2024 (date) — Fiscal year end
- March 24, 2025 (date) — Filing date of the amendment
- Delaware (location) — State of incorporation
- Burlingame, CA (location) — Company headquarters
FAQ
What specific information is being amended in this 10-K/A filing?
The filing is an amendment to the annual report for the fiscal year ended December 31, 2024, but the specific details of the amendments are not provided in this header information.
When was the original 10-K filed, if this is an amendment?
The filing date for this amendment is March 24, 2025. The original 10-K filing date is not explicitly stated in this header, but it would have been filed prior to this amendment.
What is Innoviva, Inc.'s primary business sector?
Innoviva, Inc. is classified under Pharmaceutical Preparations [2834].
Where is Innoviva, Inc. headquartered?
Innoviva, Inc.'s principal executive offices are located at 1350 Old Bayshore Highway, Suite 400, Burlingame, CA 94010.
What is the SEC file number for Innoviva, Inc.?
The Commission File Number for Innoviva, Inc. is 000-30319.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on March 24, 2025 regarding Innoviva, Inc. (INVA).